Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Elevation Oncology Inc’s stock clocked out at $3.80, down -5.24% from its previous closing price of $4.01. In other words, the price has decreased by -$5.24 from its previous closing price. On the day, 0.99 million shares were traded. ELEV stock price reached its highest trading level at $4.07 during the session, while it also had its lowest trading level at $3.75.
Ratios:
To gain a deeper understanding of ELEV’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.22 and its Current Ratio is at 21.22. In the meantime, Its Debt-to-Equity ratio is 0.55 whereas as Long-Term Debt/Eq ratio is at 0.55.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on March 01, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $7.
On May 30, 2023, SVB Securities Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $5 to $8.
On December 23, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $12.H.C. Wainwright initiated its Buy rating on December 23, 2021, with a $12 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELEV now has a Market Capitalization of 184874176 and an Enterprise Value of 131904240.
Stock Price History:
Over the past 52 weeks, ELEV has reached a high of $5.89, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is -7.69%, while the 200-Day Moving Average is calculated to be 111.71%.
Shares Statistics:
It appears that ELEV traded 1.24M shares on average per day over the past three months and 567370 shares per day over the past ten days. A total of 42.42M shares are outstanding, with a floating share count of 37.99M. Insiders hold about 21.92% of the company’s shares, while institutions hold 66.21% stake in the company. Shares short for ELEV as of 1711584000 were 5005555 with a Short Ratio of 4.03, compared to 1709164800 on 3605428. Therefore, it implies a Short% of Shares Outstanding of 5005555 and a Short% of Float of 11.44.
Earnings Estimates
The dynamic stock of Elevation Oncology Inc (ELEV) is currently being evaluated by a team of Elevance Health, Inc. analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.97, with high estimates of $232.21 and low estimates of $3.80.
